Overview
At GeneXplore, we are transforming the future of healthcare with innovative gene editing solutions that address critical genetic disorders. Our proprietary technology enables precise modifications to genes, which can potentially cure debilitating diseases. We've successfully completed our initial lab trials, demonstrating efficacy in correcting genetic mutations in vitro, which has led to promising results in our first target condition: Cystic Fibrosis. With an increasing incidence of genetic disorders, the market for gene editing therapy is projected to reach $6 billion by 2028. We are strategically positioned to capture market share with our unique technology and the expertise of our team, which includes leading scientists and biotech entrepreneurs. Currently, we have achieved several key milestones, including securing laboratory space, obtaining necessary regulatory clearances for our research, and forming strategic partnerships with prominent academic institutions. To take our next steps, we are actively raising $280,000, which will enable us to finalize product development, conduct clinical trials, and prepare for commercialization. The investment will also support our efforts…
Use of funds
The $280,000 will be allocated as follows:
- Research and Development: $150,000 for continued laboratory experiments and clinical trial preparations.
- Regulatory Compliance: $50,000 dedicated to navigating the regulatory environment and ensuring compliance with health authorities.
- Marketing and Business Development: $50,000 to build our brand presence in the biotech community and engage with key stakeholders.
- Operational Expenses: $30,000 for hiring additional staff and laboratory maintenance.
Open case
Open this case to get the detailed business plan and direct contact with the founder or seeker.